-
Je něco špatně v tomto záznamu ?
Histamine increases the level of IFNγ produced by HIV-1 specific CTLs and this production depends on total IgE level
J. Hanzlikova, D. Sedlacek, M. Liska, J. Gorcikova, T. Vlas, S. Amiramini, P. Panzner, M. Maly,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- CD8-pozitivní T-lymfocyty imunologie MeSH
- histamin imunologie MeSH
- HIV infekce imunologie MeSH
- HIV-1 imunologie MeSH
- imunoglobulin E biosyntéza imunologie MeSH
- interferon gama biosyntéza imunologie MeSH
- lidé MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
BACKGROUND: The HIV (human immunodeficiency virus) population remains a global concern whose treatment is effective, though not yet optimal. Immune based therapies have thus far been disappointing and still need to be explored further. Based on published data suggesting that the functions of cytotoxic CD8+ T lymphocytes (CTL) can be improved by histamine, we investigated the effect of histamine in vitro on HIV-1 specific CD8+ T lymphocytes in HIV+ subjects. RESULTS: 60 HIV+ subjects were included in the study. We evaluated CTL function by IFNγ (interferon gamma) production (using the enzyme-linked immunospot assay (Elispot), BD Bioscience). Changes in the production of IFNγ after incubation with histamine were compared with the levels of total IgE (immunoglobulin E, measured using a Dade Behring analyzer), because histamine is endogenously released through IgE. Activation of HIV-specific CTL by histamine occurs via H2R (histamine receptors). Thus we attempted to block this activation using cimetidine (antagonist H2R). CONCLUSIONS: We found an increase in IFNγ production after the activation of HIV-1 specific CD8+ T lymphocytes by histamine (this elevation was blocked by cimetidine), furthermore, we demonstrated a negative correlation between the production of IFNγ and levels of total IgE.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12024311
- 003
- CZ-PrNML
- 005
- 20200722150156.0
- 007
- ta
- 008
- 120815s2012 ne f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jim.2011.10.006 $2 doi
- 035 __
- $a (PubMed)22037448
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Hanzlíková, Jana $7 xx0064365 $u Department of Immunology and Allergology in Faculty Hospital Pilsen, Alej Svobody 80, 30460 Pilsen, Czech Republic.
- 245 10
- $a Histamine increases the level of IFNγ produced by HIV-1 specific CTLs and this production depends on total IgE level / $c J. Hanzlikova, D. Sedlacek, M. Liska, J. Gorcikova, T. Vlas, S. Amiramini, P. Panzner, M. Maly,
- 520 9_
- $a BACKGROUND: The HIV (human immunodeficiency virus) population remains a global concern whose treatment is effective, though not yet optimal. Immune based therapies have thus far been disappointing and still need to be explored further. Based on published data suggesting that the functions of cytotoxic CD8+ T lymphocytes (CTL) can be improved by histamine, we investigated the effect of histamine in vitro on HIV-1 specific CD8+ T lymphocytes in HIV+ subjects. RESULTS: 60 HIV+ subjects were included in the study. We evaluated CTL function by IFNγ (interferon gamma) production (using the enzyme-linked immunospot assay (Elispot), BD Bioscience). Changes in the production of IFNγ after incubation with histamine were compared with the levels of total IgE (immunoglobulin E, measured using a Dade Behring analyzer), because histamine is endogenously released through IgE. Activation of HIV-specific CTL by histamine occurs via H2R (histamine receptors). Thus we attempted to block this activation using cimetidine (antagonist H2R). CONCLUSIONS: We found an increase in IFNγ production after the activation of HIV-1 specific CD8+ T lymphocytes by histamine (this elevation was blocked by cimetidine), furthermore, we demonstrated a negative correlation between the production of IFNγ and levels of total IgE.
- 650 _2
- $a CD8-pozitivní T-lymfocyty $x imunologie $7 D018414
- 650 _2
- $a HIV infekce $x imunologie $7 D015658
- 650 _2
- $a HIV-1 $x imunologie $7 D015497
- 650 _2
- $a histamin $x imunologie $7 D006632
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunoglobulin E $x biosyntéza $x imunologie $7 D007073
- 650 _2
- $a interferon gama $x biosyntéza $x imunologie $7 D007371
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Sedláček, D
- 700 1_
- $a Liska, M
- 700 1_
- $a Gorcikova, J
- 700 1_
- $a Vlas, Tomáš $7 jx20090623009
- 700 1_
- $a Amiramini, S $7 gn_A_00005613
- 700 1_
- $a Panzner, P
- 700 1_
- $a Malý, M
- 773 0_
- $w MED00010028 $t Journal of immunological methods $x 1872-7905 $g Roč. 375, č. 1-2 (2012), s. 1-6
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22037448 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120815 $b ABA008
- 991 __
- $a 20200722150153 $b ABA008
- 999 __
- $a ok $b bmc $g 946459 $s 781639
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 375 $c 1-2 $d 1-6 $i 1872-7905 $m Journal of immunological methods $n J Immunol Methods $x MED00010028
- LZP __
- $a Pubmed-20120815/12/02
